56
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Value of Steroid Receptor Concentration and Flow Cytometrical Dna Measurements in Stage I-Ii Endometrial Carcinoma

, , , , , & show all
Pages 595-599 | Published online: 08 Jul 2009

References

  • World Health Organization. Cancer incidence in five continents vol IV. In collaboration with Peachman D, and Whe-Ian S, J Waterhouse, C Muir, K Shanmugaratnam, J Powell. IARC, Lyon 1982
  • Kottmeier HL. Report presented by the cancer committee to the general assembly of FIGO. New York, April 1970. Int J Gynaecol Obstet 1971; 9: 172–9
  • Hendrickson M R, Kempson RL. Surgical pathology of the uterine corpus. Major problems in pathology, J L Benninton. WB Saunders, Philadelphia 1980; 12
  • Surwit E A, Joelsson I, Einhorn N. Adjunctive radiation therapy in the management of stage I cancer of the endome-trium. Obstet Gynecol 1981; 58: 590–5
  • Kauppila A, Grönroos M, Nieminen U. Clinical outcome in endometrial cancer. Obstet Gynecol 1982; 60: 473–8
  • Onsrud M, Kolstad P, Normann T. Postoperative external pelvic irradiation in carcinoma of the corpus stage I: a controlled clinical trial. Gynecol Oncol 1976; 4: 222–31
  • Grundsell H, Henriksson H, Johnsson J E, Laurin J, Tropé C. Histological grading and treatment failures in carcinoma of the uterine body. Ann Chir Gynaecol 1980; 69: 65–9
  • Friedlander M, Hedley D W, Taylor JW. Clinical and biological significance of aneuploidy in human tumors. J Clin Pathol 1984; 37: 961–74
  • Atkin N B, Richards B M, Ross AI. The deoxynbonucleic acid content of carcinoma of the uterus: An assessment of its possible significance in relation to histopathology and clinical course, based on data from 165 cases. Br J Cancer 1959; 13: 773–87
  • Heyman J. The so-called Stockholm method and the results of treatment of uterine cancer at the Radiumhemmet. Acta Radiol 1935; 16: 129–48
  • Wrange Ö, Nordenskjöld B, Silfverswärd C, Granberg P O, Gustafsson JÅ. Isoelectric focusing of estradiol receptor protein from human mammary carcinoma—a comparison to sucrose gradient analysis. Eur J Cancer 1976; 12: 695–700
  • Korenman S G, Dukes BA. Specific estrogen binding by the cytoplasm of human breast carcinoma. J Clin Endocrinol Metab 1970; 30: 639–45
  • Norgren A, Borg Å, Fernö M, Johansson U, Lindahl B, Tsiobanelis K. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer. Anticancer Res 1982; 2: 315–20
  • Vindelöv L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Vir-chows Arch Cell Pathol 1977; 24: 227–42
  • Tnbukait B, Gustafsson H, Esposti P. Ploidy and proliferation in human bladder tumors as measured by flow-cytome-tric DNA-analysis and its relations to histopathology and cytology. Cancer 1979; 43: 1742–51
  • Ewers S B, Långström E, Baldetorp B, Killander D. Flowcy-tometric DNA analysis in primary breast carcinomas and clinicopathological correlation. Cytometry 1984; 5: 408–19
  • Howard A, Pelc SR. Nuclear incorporation of P as demonstrated by autoradiographs. Exp Cell Res 1951; 2: 178–87
  • Lindahl B, Alm P, Fernö M, Grundsell H, Norgren A, Tropé C. Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion. Anticancer Res 1986; 6: 1317–20
  • Lindahl B, Alm P, Fernö M, et al. Prognostic value of flow cytometncal DNA measurements in stage I—II endometrial carcinoma: correlations with steroid receptor concentration, tumor myometrial invasion, and degree of differentiation. Anticancer Res 1987; 7: 791–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.